| 1 |
Teshome MK, Najib K, Nwagbara CC, et al. Patent foramen ovale: a comprehensive review [J]. Curr Probl Cardiol, 2020, 45(2): 100392.
|
| 2 |
Mac Grory B, Ohman EM, Feng W, et al. Advances in the management of cardioembolic stroke associated with patent foramen ovale [J]. BMJ, 2022, 376: e063161.
|
| 3 |
Kavinsky CJ, Szerlip M, Goldsweig AM, et al. SCAI guidelines for the management of patent foramen ovale [J]. Journal of the Society for Cardiovascular Angiography & Interventions, 2022, 1(4): 100039.
|
| 4 |
Windecker S, Stortecky S, Meier B. Paradoxical embolism [J]. J Am Coll Cardiol, 2014, 64(4): 403-415.
|
| 5 |
Cvetković D, Živković V, Nikolić S. Patent foramen ovale, paradoxical embolism and fatal coronary obstruction [J]. Forensic Sci Med Pathol, 2018, 14(2): 258-262.
|
| 6 |
Bai H, Cho LD, Cooke PV, et al. Endovascular intervention for May-Thurner syndrome in a pregnant patient with a patent foramen ovale and paradoxical embolism [J]. Vasc Endovascular Surg, 2022, 56(5): 517-520.
|
| 7 |
Bova C, Calcaterra R, De Vuono A, et al. Pulmonary embolism and renal artery thrombosis in a patient with patent foramen ovale [J]. Acta Biomed, 2022, 93(S1): e2022209.
|
| 8 |
Kouskov OS, Nichols DJ, O’Hearn DJ. Paradoxical arterial embolism involving both upper extremities in a patient with pulmonary embolism and a patent foramen ovale [J]. Clin Appl Thromb Hemost, 2011, 17(6): E98-E101.
|
| 9 |
Rigatelli G, Dell’Avvocata F, Cardaioli P, et al. Shut that door: a man with contemporaneous multisite paradoxical embolization [J]. Cardiovasc Revasc Med, 2009, 10(2): 125-127.
|
| 10 |
Thanigaraj S, Zajarias A, Valika A, et al. Caught in the act: serial, real time images of a thrombus traversing from the right to left atrium across a patent foramen ovale [J]. Eur J Echocardiogr, 2006, 7(2): 179-181.
|
| 11 |
Pires MIFB, Almeida I, Santos JM, et al. Thrombus in transit through a patent foramen ovale: catch it if you can-a case report [J]. Eur Heart J Case Rep, 2021, 5(10): ytab382.
|
| 12 |
Härtl J, Berndt M, Poppert H, et al. Histology of cerebral clots in cryptogenic stroke varies according to the presence of a patent foramen ovale [J]. Int J Mol Sci, 2022, 23(16): 9474.
|
| 13 |
Benvenuti F, Meucci F, Vuolo L, et al. Relation between the size of patent foramen ovale and the volume of acute cerebral ischemic lesion in young patients with cryptogenic ischemic stroke [J]. Neurol Sci, 2022, 43(1): 453-458.
|
| 14 |
Le Moigne E, Timsit S, Ben Salem D, et al. Patent foramen ovale and ischemic stroke in patients with pulmonary embolism: a prospective cohort study [J]. Ann Intern Med, 2019, 170(11): 756-763.
|
| 15 |
Di Stefano V, Di Fulvio M, Di Liberato L, et al. Paradoxical embolism through a patent foramen ovale from central venous catheter thrombosis: a potential cause of stroke [J]. J Neurol Sci, 2020, 414: 116820.
|
| 16 |
Osgood M, Budman E, Carandang R, et al. Prevalence of pelvic vein pathology in patients with cryptogenic stroke and patent foramen ovale undergoing MRV pelvis [J]. Cerebrovasc Dis, 2015, 39(3-4): 216-223.
|
| 17 |
Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial septal aneurysm [J]. Stroke, 2002, 33(3): 706-711.
|
| 18 |
Samuel S, Reddy ST, Parsha KN, et al. Routine surveillance of pelvic and lower extremity deep vein thrombosis in stroke patients with patent foramen ovale [J]. J Thromb Thrombolysis, 2021, 51(4): 1150-1156.
|
| 19 |
Sc C, Jh M, Gm W, et al. Paradoxical emboli from calf and pelvic veins in cryptogenic stroke [J]. J Neuroimaging, 2003, 13(3): 218-223.
|
| 20 |
Wessler BS, Thaler DE, Ruthazer R, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database [J]. Circ Cardiovasc Imaging, 2014, 7(1): 125-131.
|
| 21 |
Thaler DE, Ruthazer R, Weimar C, et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs [J]. Neurology, 2014, 83(3): 221-226.
|
| 22 |
Yan C, Li H. Preliminary investigation of in situ thrombus within patent foramen ovale in patients with and without stroke [J]. JAMA, 2021, 325(20): 2116-2118.
|
| 23 |
潘双杰, 何远宏, 赵源征, 等. 中性粒细胞与淋巴细胞的比值与卵圆孔未闭患者卒中相关性研究 [J]. 中国现代医生, 2021, 59(18): 91-94.
|
| 24 |
Lezcano EJ, Ruiz JR, Lacambra I. Device thrombosis during the percutaneous closure of a patent foramen ovale [J]. Rev Esp Cardiol, 2011, 64(6): 540-541.
|
| 25 |
Rigatelli G, Zuin M, Dell’Avvocata F, et al. Light anti-thrombotic regimen for prevention of device thrombosis and/or thrombotic complications after interatrial shunts device-based closure [J]. Eur J Intern Med, 2020, 74: 42-48.
|
| 26 |
Blanc-Vannet S, Vautrin E, Piliero N. Massive device thrombosis, multiple embolisms, and delayed-onset heparin-induced thrombocytopenia: a rare but severe complication of patent foramen ovale closure [J]. Eur Heart J, 2022, 43(25): 2425.
|
| 27 |
Aarnink EW, Huijboom MFM, Bor WL, et al. Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review [J]. Thromb Res, 2022, 215: 41-51.
|
| 28 |
Sun H, Zhou C, Xu L, et al. A meta-analysis of the association of atrial septal abnormalities and atrial vulnerability [J]. Medicine, 2021, 100(35): e27165.
|
| 29 |
Acampa M, Lazzerini PE, Guideri F, et al. Electrocardiographic predictors of silent atrial fibrillation in cryptogenic stroke [J]. Heart Lung Circ, 2019, 28(11): 1664-1669.
|
| 30 |
徐振兴. 阵发性室上性心动过速患者房颤的心房易损性及其影响因素 [D]. 济南: 山东大学, 2014.
|
| 31 |
Cotter PE, Martin PJ, Pugh PJ, et al. Increased incidence of interatrial block in younger adults with cryptogenic stroke and patent foramen ovale [J]. Cerebrovasc Dis Extra, 2011, 1(1): 36-43.
|
| 32 |
Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause [J]. Stroke, 2000, 31(2): 398-403.
|
| 33 |
Rigatelli G, Aggio S, Cardaioli P, et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm [J]. JACC Cardiovasc Interv, 2009, 2(7): 655-662.
|
| 34 |
Mahfouz RA, Alawady WS, Salem A, et al. Atrial dyssynchrony and left atrial stiffness are risk markers for cryptogenic stroke in patients with patent foramen ovale [J]. Echocardiography, 2017, 34(12): 1888-1894.
|
| 35 |
Rigatelli G, Zuin M, Fong A. Computational flow dynamic analysis of right and left atria in patent foramen ovale: potential links with atrial fibrillation [J]. J Atr Fibrillation, 2018, 10(5): 1852.
|
| 36 |
Rigatelli G, Zuin M, Roncon L. Increased blood residence time as markers of high-risk patent foramen ovale [J]. Transl Stroke Res, 2023, 14(3): 304-310.
|
| 37 |
Guedeney P, Laredo M, Zeitouni M, et al. Supraventricular arrhythmia following patent foramen ovale percutaneous closure [J]. JACC Cardiovasc Interv, 2022, 15(22): 2315-2322.
|
| 38 |
Apostolos A, Drakopoulou M, Gregoriou S, et al. Supraventricular arrhythmia after percutaneous PFO closure: is nickel hypersensitivity the missing piece of the puzzle? [J]. JACC Cardiovasc Interv, 2023, 16(3): 359.
|
| 39 |
Andersen A, Matzen KL, Andersen G, et al. Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study [J]. Catheter Cardiovasc Interv, 2022, 99(5): 1551-1557.
|
| 40 |
周建军, 胡娅莉. 易栓症的发生机制和防治 [J]. 中国实用妇科与产科杂志, 2009, 25(5): 332-335.
|
| 41 |
Carano N, Agnetti A, Hagler DJ, et al. Acute myocardial infarction in a child: possible pathogenic role of patent foramen ovale associated with heritable thrombophilia [J]. Pediatrics, 2004, 114(2): e255-e258.
|
| 42 |
Botto N, Spadoni I, Giusti S, et al. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale [J]. Stroke, 2007, 38(7): 2070-2073.
|
| 43 |
Giardini A, Donti A, Formigari R, et al. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia [J]. Am J Cardiol, 2004, 94(8): 1012-1016.
|
| 44 |
Hviid CVB, Simonsen CZ, Hvas AM. Recurrence risk in patients with cryptogenic stroke, patent foramen ovale, and thrombophilia: a systematic review and meta-analysis [J]. Thromb Haemost, 2019, 119(11): 1839-1848.
|
| 45 |
Liu K, Song B, Palacios IF, et al. Patent foramen ovale attributable cryptogenic embolism with thrombophilia has higher risk for recurrence and responds to closure [J]. JACC Cardiovasc Interv, 2020, 13(23): 2745-2752.
|
| 46 |
樊黎明. 血浆高同型半胱氨酸与脑卒中的关系与干预进展 [J]. 中国误诊学杂志, 2021, 16(4): 383-384.
|
| 47 |
Deng W, McMullin D, Inglessis-Azuaje I, et al. Effect of patent foramen ovale closure after stroke on circulatory biomarkers [J]. Neurology, 2021, 97(2): e203-e214.
|
| 48 |
Zuin M, Rigatelli G, Rigatelli A, et al. Correlations between serum homocysteine levels and RoPE score in patients with patent foramen ovale [J]. Heart and Vessels, 2020, 35(5): 705-711.
|
| 49 |
Omran SS, Lerario MP, Gialdini G, et al. Clinical impact of thrombophilia screening in young adults with ischemic stroke [J]. J Stroke Cerebrovasc Dis, 2019, 28(4): 882-889.
|
| 50 |
Buber J, Guetta V, Orion D, et al. Patent foramen ovale closure among patients with hypercoagulable states maintained on antithrombotic therapy [J]. Cardiology, 2021, 146(3): 375-383.
|